We are excited to announce the next webinar in our “EyeNovation: International Webinar Series for Ophthalmic Expertise” series, “Impact of corneal spherical aberration and pupil dynamics on premium IOLs’ optical behavior,” presented by the esteemed Professor Damien Gatinel from Hôpital Bichat-Claude Bernard, Université Paris Cité.

Professor Gatinel, a Hospital Practitioner currently on secondment at Hôpital Bichat-Claude Bernard, Université Paris Cité, has an impressive background. He has been leading the Anterior Segment and Refractive Surgery Department at the Rothschild Foundation Hospital since 2009 and serves as an Associate Professor at the International Abulcassis University of Health Sciences in Rabat, Morocco. With a PhD in applied mathematics, Professor Gatinel has pioneered a new classification of ocular optical aberrations and issued several patents, including the first design of a diffractive trifocal lens. His contributions have earned him over 25 international awards and recognition as a Knight of the Order of the Crown by the Kingdom of Belgium.

In this webinar, Professor Gatinel will:

• Analyze how corneal spherical aberration influences the optical behavior of premium intraocular lenses (IOLs), with a focus on their interaction with different corneal profiles.
• Examine how variations in pupil size affect the modulation transfer function (MTF) and other optical parameters of premium IOLs under simulated conditions.
• Apply insights from measurements and simulations to optimize the selection of premium IOLs.

If you missed this incredible opportunity to learn from a leading expert in the field and advance your ophthalmic expertise, you can review the recording below:

Stay tuned for future webinars in the EyeNovation series, as we continue to bring you the latest advancements and expert perspectives in ophthalmology. Together, we can improve patient care and push the boundaries of what is possible in this dynamic field.

The Australian and New Zealand Glaucoma Society will be hosting their 2025 ANZGS Congress, which will be held in Perth from 14 – 16 February 2025.

The congress will include the highly popular and somewhat unpredictable interactive panel and case presentations, the ACB Molteno Off-Piste Lecture, and numerous keynote presentations from the glaucoma field, along with ample opportunities for submitted papers. Their keynote presenters include:

• Professor Norbert Pfeiffer (Lowe Lecture)
• Professor Steven Tingay (ACB Molteno Lecture)
• Professor Keith Martin (Gillies Lecture)

Registration is open now! The deadline to register for this event is February 7th, 2025. Virtual and in-person registration is available. For more details on registering, click HERE.

We are thrilled to announce the next webinar in our “EyeNovation: International Webinar Series for Ophthalmic Expertise” series, “The Light Adjustable Lens: Impressions after 500 and my 2 eyes,” presented by esteemed ophthalmologist Dr. Samir Melki from Harvard Medical School. This webinar took place on October 30th, from 7:00 PM – 8:00 PM ET.

Dr. Melki, an associate professor of ophthalmology at Harvard Medical School, has an impressive background, including completing a fellowship in Cornea and Refractive Surgery at the Massachusetts Eye and Ear Infirmary, an MD PhD from Vanderbilt University, and an Ophthalmology residency at Georgetown University. He is the founder of Boston Vision, an academically-oriented practice, and has published 4 textbooks and 57 articles in respected peer-reviewed scientific journals.

In this webinar, Dr. Melki shared his LAL experience with the first 500 eyes, discussing the technology, process, and outcomes. Attendees will gain insights into:

• The process of the LAL;
• Comparison of the visual outcomes of the LAL and other IOLs;
• Patient satisfaction after LAL implantation.

Dr. Melki also discussed the success rate of monovision after LAL, the percentage of patients requesting a change in refractive aim, and his personal experience with LAL and LAL plus from a surgeon’s perspective.

You can watch the recording below:

Missed this webinar? Stay tuned for future webinars in the EyeNovation series, as we continue to bring you the latest advancements and expert perspectives in ophthalmology. Together, we can improve patient care and push the boundaries of what is possible in this dynamic field.

Report Card: The Post-Pandemic State of Vision Health in Canada

Date: Wednesday, October 30, 2024
Time: 10 am – 2 pm  
Location: Toronto Reference Library 
789 Yonge Street, Toronto, Ontario, M4W 2G8
Bram & Bluma Appel Salon (2nd floor)

This conference will present results from the newly-released Report Card Part 2, undertaken by the Canadian Council of the Blind (CCB) and Fighting Blindness Canada (FBC), which is a follow-up to the Report Card Part 1, released in October 2022. 

The report provides an update on the current state of vision health in Canada and what we can anticipate as we move forward from the post-pandemic era. The report offers insights into the key issues affecting vision health and the community of people living with vision loss. 

This is a hybrid event, meaning the same content will be offered at the same time.
For in-person registration, click HERE.
For online registration, click HERE.

You can view the 2023 Report Card below!

Date: November 3-5, 2024
Location: Valencia, Spain – Palacio de Congresos de València

EVER is the leading ophthalmological research association in Europe which covers all areas of ophthalmology and the visual sciences. One of the main activities of EVER is the organizing of a high quality research meeting every year at a location chosen for its access and congress facilities.

The 27th EVER congress will provide the perfect environment to promote the best research in vision, retina and eye, bringing together clinical, translational and basic science in a very beautiful, welcoming and dynamic city.

For more information on this innovative, scientific programming, click HERE.

The 27th EVER CONGRESS, Valencia, Spain 03/11/2024 – 05/11/2024 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 17 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity (6 credits on 3/11, 6 credits on 4/11, 5 credits on 5/11). “Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org. Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

For the past decade, the biennial Fuchs Symposium has brought together the world’s leaders in endothelial research and treatment under one roof to share the latest advancements in this exciting field. The Fuchs IX Symposium will take place at the McGill University Health Centre in Montréal, Canada. The course directors have gathered an incredible faculty that you won’t want to miss. This symposium will take place on September 27th, 2025. Be sure to save the date, registration will be open soon!

The October 2024 CJO is now available online. Here are some of the highlights: 

Resident Perspectives + visual abstract: Our talented team of residents have summarized 3 articles from this issue with a focus on what’s most relevant to ophthalmology learners here in Canada and around the globe. In addition, our October visual abstract provides a visual summary of an article on the Long-term effect of fluid volumes during the maintenance phase in neovascular age-related macular degeneration: results from Fight Retinal Blindness!

Reviews and Original Research Articles:

• Advancements in the diagnosis, prognosis, and treatment of retinoblastoma

• Evaluating smartphone fundoscopy as a pedagogical tool in medical education: a narrative review

• Routine history and physical examinations prior to cataract surgery are not beneficial

• Outcomes and risk factors for Kahook Dual Blade excisional goniotomy with concomitant phacoemulsification: a multicentre Canadian study

• Breaking bad news in ophthalmology: a pilot skills workshop for residents

• Ophthalmic diseases in meningitis within the pediatric population

Research Letters, Photo Essays, Case Reports, and more:

• Patient knowledge of pentosan polysulfate maculopathy in Alberta: a population wide survey-based study 

• Massive ciliochoroidal melanoma masquerading as conjunctival melanoma  

• Ocular Jarisch-Herxheimer reaction causing a transient sub-foveal lesion in ocular syphilis  

• Advanced intraocular retinoblastoma: evolving criteria for group E disease

• Exudative retinal detachment following laser photocoagulation for retinopathy of prematurity

• Diagnosis of a uveal melanoma arising from the choroid beneath a congenital hypertrophy of the retinal pigment epithelium: the value of microvascular flow imaging

• F. Y. Eye Column — October 2024

Follow the CJO on social media:

Facebook: CanJOphth

Instagram: @cjo_jco

LinkedIn: CJO – JCO

Twitter: @CanJOphth

This year, World Sight Day (October 10, 2024) focuses on children’s eye health around the world. We want to highlight and review the existing guidelines for the screening of retinopathy of prematurity (ROP). These guidelines, developed by key organizations in ophthalmology, aim to ensure early detection and management of ROP in preterm infants to prevent life-long visual impairment and blindness. Please note that this review reflects current clinical recommendations from leading bodies and is not a COS policy or official guideline.

Screening Eligibility

Screening is recommended for infants at the highest risk of developing ROP. The criteria include:

• Gestational age: ≤30 6/7 weeks
• Birth weight: ≤1500 grams
• Neonatal risk factors: Infants born at >1500 grams or >31 weeks may still require screening (eg, infants with hypotension or those who received oxygen supplementation)

Initial screening: The first eye exam is recommended at either 31 weeks’ postmenstrual age in infants with gestational ages less than 26 6/7 weeks at birth, and at four weeks of chronological age in infants born with a gestational ages of 27 weeks or more, whichever is later.

Follow up intervals depend on the severity of the ROP observed in the initial exam.

As we recognize World Sight Day, it is important to remember that infants who develop ROP are at a higher risk of visual disorders such as: strabismus, amblyopia, high refractive errors, cataracts and glaucoma. By raising awareness and ensuring early detection and treatment, we can help protect the vision of these vulnerable children and work towards a world where everyone has access to eye care.

Reviewed by: Dr. Marie-Josée Aubin, MD (Chair), Dr. Cynthia Qian, MD (CPD Council Chair)

References:

Jefferies, A. L. (2016). Screening examination of premature infants for retinopathy of prematurity. https://cps.ca/en/documents/position/retinopathy-of-prematurity-screening

Subramanian, S., Kern, M. D., & Deegan, W. F. III. (2023). Retinopathy of prematurity guidelines. Medscape. https://emedicine.medscape.com/article/976220-guidelines

The field of ophthalmology is constantly evolving, with new techniques, technologies, and best practices emerging regularly. To help ophthalmologists stay at the forefront of their profession, we are proud to introduce “EyeNovation: International Webinar Series for Ophthalmic Expertise.”

This innovative webinar series aims to connect ophthalmologists from around the world, fostering knowledge sharing and collaboration. Each webinar will feature renowned experts presenting on cutting-edge topics and sharing their invaluable experiences.

We are thrilled to announce our inaugural webinar, “Pearls from the Trenches: What I’ve learned from doing complex cases,” presented by esteemed ophthalmologist Dr. Steven Safran. With years of experience tackling challenging ophthalmic cases, Dr. Steven Safran will share the lessons he has learned and provide practical insights to enhance attendees’ clinical practice.

The webinar took place on September 30th from 7:00 PM to 8:00 PM EST and included a live Q&A session, allowing attendees to engage directly with Dr. Safran.

By attending this webinar, ophthalmologists will:

1. Gain valuable insights from a leading expert in the field
2. Learn practical strategies for managing complex ophthalmic cases
3. Connect with colleagues from around the globe
4. Enhance their clinical knowledge and skills

You can enjoy a recording of the webinar below:

Did you miss this live webinar? Stay tuned for future webinars in the EyeNovation series, as we continue to bring you the latest advancements and expert perspectives in ophthalmology. Together, we can improve patient care and push the boundaries of what is possible in this dynamic field.